
Andrew A. Nierenberg, MD, explains how a learning health network helps clinicians measure outcomes and redesign bipolar disorder care together with patients.
What are the guidelines for working with patients who do not respond to FDA-approved medications for bipolar disorder?
Which of the following interventions can be useful in treating treatment-resistant bipolar disorder?